Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

VCEL

Vericel Corp

CIK 0000887359 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$48.31
↑ 1.29 (2.74%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals; Risks: Fundamentals; Excluded: Options (no data)

Key stats

Market Cap
$2.40B
P/E Ratio
109.35
EPS
0.33
Dividend Yield
Not covered
52W Position
103%
Beta
1.10

Valuation multiples

Fwd P/E
95.24
PEG
0.00
P/B
6.74
P/S
8.22
EV/Revenue
7.85
ROE
6.0%
Valuation data covers 8,494/9,463 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 103%
$28.95$47.79

Latest Financials

2025-12-31 FY
Revenue
$276.26M
Net Income
$16.52M
Total Assets
$487.97M
Free Cash Flow
$24.75M

Recent news